From OncoLog, September 2013, Vol. 58,
Opioid Rotation Can Improve Pain Control and Reduce Neurotoxicity for Cancer Patients
By Markeda Wade
are a mainstay in the relief of pain—especially the chronic
cancer-related pain often encountered in the palliative care setting.
However, extended opioid use can result in tolerance, dependence, and
The symptoms of neurotoxicity—which include excessive sedation,
confusion, hallucinations, and myoclonus—result from a buildup of the
metabolites of opioids in the brain. Thus, when tolerance develops and
pain is no longer controlled, simply increasing the opioid dose, as was
commonly done in times past, may result in neurotoxicity.
In 1995, Eduardo Bruera, M.D., who was then a professor at the
University of Alberta and is now a professor in and chair of the
Department of Palliative Care and Rehabilitation Medicine at The
University of Texas MD Anderson Cancer Center, proposed the notion of
opioid rotation. In opioid rotation, the no-longer-effective opioid is
replaced with a new one—but at a much lower dose, thereby minimizing
the potential for toxicity. This is important because the most common
indication for opioid rotation is opioid-induced neurotoxicity. “The
cause of toxicity is the opioid, so that opioid needs to go,” said
Akhila Reddy, M.D., an assistant professor in the Department of
Palliative Care and Rehabilitation Medicine.
Opioid rotation is carried out using an equianalgesic table (these are
published by numerous sources, including pharmaceutical companies) in
which the morphine-equivalent daily dose of the original opioid is
calculated and then decreased by 30%–50%.
Although opioid rotation was originally met with resistance by many
clinicians—who were skeptical about cross-tolerance, which is common in
patients treated with opioid analgesics—in the past decade, opioid
rotation has become standard practice in the inpatient setting and is
usually successful. For example, in a recent Italian study, 96 of 103
opioid substitutions were successful. This success is attributable to
the daily monitoring of pain in inpatients, enabling rapid titration of
Indications for Opioid Rotation
Although uncontrolled pain and opioid-induced neurotoxicity are the most common indications for opioid rotation, the procedure can be valuable for addressing other situations, such as the need to change the route by which a particular medication is administered. For example, in patients with head and neck cancer who have radiation-induced dysphagia and thus trouble taking pills, solid medications can be switched to a long-lasting liquid form. Moreover, in patients who have renal failure, morphine can be switched to methadone. And in a non-medical but perhaps equally significant situation, opioid rotation can be implemented when a drug is not covered by a patient’s insurance.
Increasingly, opioid rotation is also being considered for use in the
outpatient setting. Recently, Dr. Reddy and her colleagues reported a
retrospective review of all outpatients seen in 1 year in MD Anderson’s
Supportive Care Clinic. Of those who were receiving strong opioids
(morphine, hydromorphone, oxycodone, methadone, or fentanyl), 31%
underwent opioid rotation, and the rotation was successful in 65% of
those cases. Of the patients who required opioid rotation, 83% did so
for uncontrolled pain and 12% for opioid-induced neurotoxicity. In the
Supportive Care Clinic at MD Anderson, nurses and pharmacists follow up
by phone with outpatients who have undergone opioid rotation to ensure
the rotation went smoothly.
In addition, physicians schedule all outpatients for follow-up within a
week of the opioid rotation. The close monitoring via nurse calls and
the short intervals to follow-up increase the likelihood that the
opioid rotation will be successful and help prevent both overdosing and
Dr. Reddy recommended that a patient’s support system and likelihood of
compliance be considered in the decision whether to use opioid rotation
in an outpatient clinic. “Outpatients who do not follow up after opioid
rotation and those who have unsuccessful opioid rotation have shorter
survival times,” she said.
Opioid rotation has its limits for managing cancer pain in outpatients.
Patients who have a poor performance status benefit more from opioid
rotation in an inpatient setting, where they can be assessed more
frequently than outpatients.
In any instance, Dr. Reddy advised, opioid rotation can be dangerous if
performed by someone who is inexperienced. In the management of cancer
pain, because of the high drug doses needed in some patients, imprecise
opioid rotation could lead to overdose or even death. A palliative care
or pain service consultation is advisable for patients requiring an
de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity
reduction in terminal cancer patients. J Pain Symptom Manage. 1995;10:378–384.
Reddy A, Yennurajalingam S, Pulivarthi K, et al. Frequency, outcome,
and predictors of success within 6 weeks of an opioid rotation among
outpatients with cancer receiving strong opioids. Oncologist.
information, contact Dr. Akhila Reddy at 13-792-6085 or firstname.lastname@example.org.
Home/Current Issue | Previous Issues | Articles by Topic | Patient Education
About Oncolog | Contact OncoLog | Sign Up for E-mail Alerts
©2014 The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Houston, TX 77030
1-877-MDA-6789 (USA) / 1-713-792-3245